104 related articles for article (PubMed ID: 25227441)
1. Letter to the editor.
Kono Y; Shimizu Y; Wakatsuki Y; Yasui N; Aso T; Kawamoto H; Kurihara H
Radiat Prot Dosimetry; 2015 Mar; 163(4):533-4. PubMed ID: 25227441
[No Abstract] [Full Text] [Related]
2. Minimizing nuclear medicine technologist radiation exposure during 131I-MIBG therapy.
Turpin BK; Morris VR; Lemen L; Weiss BD; Gelfand MJ
Health Phys; 2013 Feb; 104(2 Suppl 1):S43-6. PubMed ID: 23287519
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
Mastrangelo S; Rufini V; Ruggiero A; Di Giannatale A; Riccardi R
Pediatr Blood Cancer; 2011 Jul; 56(7):1032-40. PubMed ID: 21344615
[TBL] [Abstract][Full Text] [Related]
4. Meta-iodobenzylguanidine in neuroblastoma: from diagnosis to therapy.
Mitjavila M
Nucl Med Commun; 2002 Jan; 23(1):3-4. PubMed ID: 11748431
[No Abstract] [Full Text] [Related]
5. 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status.
Tepmongkol S; Heyman S
Med Pediatr Oncol; 1999 Jun; 32(6):427-31; discussion 432. PubMed ID: 10358701
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma.
Ben Arush MW; Ben Itzhak O; Yossilevski G; El Hasid R; Postovsky S; Israel O
Med Pediatr Oncol; 1999 Oct; 33(4):418-9. PubMed ID: 10491557
[No Abstract] [Full Text] [Related]
7. [Role of 123-I-metaiodobenzylguanidine imaging as a component in the diagnosis and treatment of neuroblastoma].
Ivanova AA; Sokolov AV; Ialfimov AN; Savchenko ON
Vopr Onkol; 2008; 54(4):521-4. PubMed ID: 18942414
[TBL] [Abstract][Full Text] [Related]
8. Targeted radiotherapy for neuroblastoma.
Meller S
Arch Dis Child; 1997 Nov; 77(5):389-91. PubMed ID: 9487957
[No Abstract] [Full Text] [Related]
9. Radiation exposure in nurses during care of
Taniguchi Y; Wakabayashi H; Inaki A; Kayano D; Yamada M; Kinuya S
Ann Nucl Med; 2020 Jun; 34(6):441-447. PubMed ID: 32297135
[TBL] [Abstract][Full Text] [Related]
10. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
11. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
[TBL] [Abstract][Full Text] [Related]
13. Hypothyroidism after treatment of metastatic neuroblastoma.
Lackner H; Urban C; Sovinz P; Nebl A; Schmidt S; Benesch M; Schwinger W
Pediatr Blood Cancer; 2010 Oct; 55(4):768. PubMed ID: 20806369
[No Abstract] [Full Text] [Related]
14. Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during
Taniguchi Y; Wakabayashi H; Yoneyama H; Chen Z; Morino K; Otosaki A; Yamada M; Inaki A; Kayano D; Kinuya S
Sci Rep; 2022 Jan; 12(1):47. PubMed ID: 34996922
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy.
Melbourne GJ; Lehm JP
Eur J Nucl Med; 2000 Nov; 27(11):1732-3. PubMed ID: 11105832
[No Abstract] [Full Text] [Related]
16. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
17. Estimated Internal and External Radiation Exposure of Caregivers of Patients With Pediatric Neuroblastoma Undergoing 131I Metaiodobenzylguanidine Therapy: A Prospective Pilot Study.
Han S; Yoo SH; Koh KN; Lee JJ
Clin Nucl Med; 2017 Apr; 42(4):271-274. PubMed ID: 28098666
[TBL] [Abstract][Full Text] [Related]
18. [Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG].
Sudbrock F; Eschner W; Schmidt M; Simon T; Hero B; Schicha H
Nuklearmedizin; 2006; 45(6):254-61. PubMed ID: 17149494
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents.
Mairs RJ
Eur J Cancer; 1999 Aug; 35(8):1171-3. PubMed ID: 10615225
[No Abstract] [Full Text] [Related]
20. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]